- Author:
Peng WANG
1
,
2
,
3
;
Yi-Chen SUN
1
;
Wen-Hua LU
1
;
Peng HUANG
1
;
Yumin HU
1
;
Author Information
- Publication Type:Journal Article
- MeSH: Capsaicin; Carcinoma, Pancreatic Ductal; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial Cells; Genes, ras; Humans; NADPH Oxidases; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; Signal Transduction; Transfection
- From:Chinese Journal of Cancer 2015;34(4):166-176
- CountryChina
- Language:English
-
Abstract:
INTRODUCTIONOncogenic activation of the K-ras gene occurs in >90% of pancreatic ductal carcinoma and plays a critical role in the pathogenesis of this malignancy. Increase of reactive oxygen species (ROS) has also been observed in a wide spectrum of cancers. This study aimed to investigate the mechanistic association between K-ras-induced transformation and increased ROS stress and its therapeutic implications in pancreatic cancer.
METHODSROS level, NADPH oxidase (NOX) activity and expression, and cell invasion were examined in human pancreatic duct epithelial E6E7 cells transfected with K-ras (G12V) compared with parental E6E7 cells. The cytotoxic effect and antitumor effect of capsaicin, a NOX inhibitor, were also tested in vitro and in vivo.
RESULTSK-ras transfection caused activation of the membrane-associated redox enzyme NOX and elevated ROS generation through the phosphatidylinositol 3'-kinase (PI3K) pathway. Importantly, capsaicin preferentially inhibited the enzyme activity of NOX and induced severe ROS accumulation in K-ras-transformed cells compared with parental E6E7 cells. Furthermore, capsaicin effectively inhibited cell proliferation, prevented invasiveness of K-ras-transformed pancreatic cancer cells, and caused minimum toxicity to parental E6E7 cells. In vivo, capsaicin exhibited antitumor activity against pancreatic cancer and showed oxidative damage to the xenograft tumor cells.
CONCLUSIONSK-ras oncogenic signaling causes increased ROS stress through NOX, and abnormal ROS stress can selectively kill tumor cells by using NOX inhibitors. Our study provides a basis for developing a novel therapeutic strategy to effectively kill K-ras-transformed cells through a redox-mediated mechanism.